EDRH
WST icon

Edmond de Rothschild Holding’s West Pharmaceutical WST Stock Holding History

Edmond de Rothschild Holding’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-254
Closed -$63.7K – 655
2026
Q1 		$63.7K Sell
254
-68
-21% -$16.9K ﹤0.01% 435
2025
Q4 		$88.6K Hold
322
– – ﹤0.01% 431
2025
Q3 		$84.5K Hold
322
– – ﹤0.01% 437
2025
Q2 		$70.5K Hold
322
– – ﹤0.01% 435
2025
Q1 		$72.1K Buy
322
+95
+42% +$26.2K ﹤0.01% 440
2024
Q4 		$74.4K Buy
+227
New +$71.4K ﹤0.01% 468

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Edmond de Rothschild Holding's WST Position: Q2 2026 in Review

Edmond de Rothschild Holding sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 254 shares — an estimated $63.7K sold.

Edmond de Rothschild Holding first reported a position in WST in Q4 2024 and held it in 6 quarters. The position peaked at $88.6K in Q4 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Edmond de Rothschild Holding reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 254 West Pharmaceutical shares in Q2 2026, an estimated $63.7K.
  • Edmond de Rothschild Holding first reported a position in West Pharmaceutical in Q4 2024 and held it in 6 quarters.
  • Edmond de Rothschild Holding's West Pharmaceutical position peaked at $88.6K in Q4 2025.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.